
Please try another search
By Sam Boughedda
Investing.com -- ANI Pharmaceuticals Inc (NASDAQ:ANIP) shares fell 25% on Tuesday after reporting its fourth-quarter and full-year earnings that saw earnings per share fail to beat analyst estimates.
The Baudette, Minnesota-based company announced earnings per share of 54 cents on revenue of $60.93 million. Analysts polled by Investing.com anticipated EPS of 75 cents on revenue of $56.3 million.
The company also reported full-year 2021 revenues of $216.1 million.
“The past few months have been an exciting time for ANI as we completed the build out of our Rare Disease business team. Our senior leadership has experience across over 20 Rare Disease launches and 75% of our high-performing sales colleagues have won President’s Club or equivalent in the past few years," said Nikhil Lalwani, president and CEO of ANI.
"The strengthening of our balance sheet through our debt refinancing and recent $75 million equity raise, position us well to deliver long-term sustainable growth,” concluded Lalwani.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.